Peptides DB
Research-centric peptide and protocol reference hub
Study 14 of 15Triptorelin literatureGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · Case reportHigh-impact journal2002

Ovarian hyperstimulation-like syndrome after administration of triptorelin to a woman with endometriosis.

A single dose of triptorelin can lead to ovarian hyperstimulation-like syndrome, as evidenced by significant ovarian enlargement and multiple follicles, but symptoms resolved spontaneously.

Read at Gynecological endocrinology : the official journal of the International Society of Gynecological EndocrinologyAdd to compare

Where it sits

this study against the rest of the triptorelin corpus
1
Preclinical
10
Observational · this one
0
Open-label
3
Randomised
1
Reviews

Summary and findings

This case report describes ovarian hyperstimulation-like syndrome following a single administration of triptorelin (Decapeptyl 3.75 mg) in a woman with a history of endometriosis. Symptoms included abdominal pressure, nausea, and pelvic pain, with ultrasound findings indicating bilateral ovarian enlargement and multiple follicles. The condition resolved spontaneously during treatment, and a spontaneous pregnancy was reported afterward.

How much of this paper we could read: full text read (0.80). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Bilateral ovarian enlargement: right 74 x 62 mm, left 62 x 53 mm.2002

Abstract

The authors’ words, as Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology supplied them

Ovarian hyperstimulation after a single dose of gonadotropin-releasing hormone (GnRH) analog is a rare phenomenon. A case of ovarian hyperstimulation-like syndrome after sole administration of triptorelin (Decapeptyl 3.75 mg) is reported in a woman who had undergone surgery for an endometriotic cyst. After administration of the drug, abdominal pressure increased with nausea and diffuse pelvic pain. Ultrasound examination showed bilateral enlargement of the ovaries (right 74 x 62 mm, left 62 x 53 mm), more than 10 follicles ranging in diameter from 15-25 mm, proliferative endometrium 7 mm thick and fluid in the Douglas pouch up to 25 x 23 mm thick. Estradiol plasma level was in the normal range. The syndrome spontaneously resolved in the course of treatment and a spontaneous pregnancy occurred when the triptorelin effect disappeared.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the Triptorelin corpus

CDevelopment and Preclinical Evaluation of Six-Transmembrane Epithelial Antigen of Prostate 2 Targeted PET Probes: A Case of Drug Repurposing Based on Molecular Docking.Journal of medicinal chemistry · 2016 · SUVmax 1.8 in 22Rv1 xenografts for 68Ga-Trip-5.AnimalBGonadotropin-releasing hormone analog treatment for the prevention of treatment-related ovarian failure and infertility in women of reproductive age with Hodgkin lymphoma.Leukemia & lymphoma · 2008 · 50 patients (82%) recovered regular menses.HumanASignificance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: evaluation of cardiovascular events in a randomized trial.Scandinavian journal of urology and nephrology · 2011 · 33% of patients with pretreatment cardiovascular diseases had a cardiovascular event during PEP treatment.HumanAThe two-shot protocol. A randomized controlled trial of a novel two-injection ovarian stimulation strategy.Human reproduction (Oxford, England) · 2023 · n=194 · Mean number of MII oocytes: 8.09 ± 5.87 vs 9.11 ± 6.86; MD -1.02 [95% CI: -2.83; 0.79]HumanAComparative effectiveness of luteal phase support strategies in natural cycle frozen-thawed embryo transfer: a systematic review and network meta-analysis.European journal of obstetrics, gynecology, and reproductive biology · 2026 · Not reported in abstract.reviewCProposed Method for Mass Spectrometric Measurement of the Gonadotropin-Releasing Hormone Agonist Deslorelin.Toxics · 2026 · Detectability optimized to <1 ppb.Animal